ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 31 filers reported holding ASCENDIS PHARMA A/S in Q4 2016. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $33,137,000 | +2018.7% | 251,900 | +1713.7% | 8.24% | +1472.1% |
| Q1 2020 | $1,564,000 | -85.3% | 13,889 | -84.6% | 0.52% | -81.7% |
| Q1 2019 | $10,631,000 | +370.2% | 90,325 | -19.7% | 2.87% | +84.1% |
| Q3 2016 | $2,261,000 | -15.9% | 112,497 | -44.5% | 1.56% | +13.5% |
| Q2 2016 | $2,687,000 | -22.6% | 202,520 | +8.2% | 1.37% | +8.0% |
| Q1 2016 | $3,473,000 | -33.4% | 187,220 | -34.3% | 1.27% | -45.0% |
| Q4 2015 | $5,217,000 | +9.3% | 284,785 | +5.6% | 2.31% | -29.4% |
| Q3 2015 | $4,775,000 | +33.3% | 269,785 | +33.2% | 3.27% | +85.0% |
| Q2 2015 | $3,581,000 | – | 202,525 | – | 1.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,046,832 | $240,912,000 | 24.02% |
| RA Capital Management | 4,132,442 | $486,388,000 | 20.97% |
| VHCP Management II, LLC | 504,210 | $59,346,000 | 17.36% |
| Ghost Tree Capital, LLC | 385,000 | $45,315,000 | 11.84% |
| Sofinnova Investments, Inc. | 998,538 | $117,528,000 | 11.33% |
| Foresite Capital Management IV, LLC | 245,424 | $28,886,000 | 10.38% |
| Avoro Capital Advisors LLC | 1,795,000 | $211,272,000 | 9.14% |
| Orbimed Advisors | 3,970,673 | $467,348,000 | 7.24% |
| Eventide Asset Management | 1,698,648 | $199,931,000 | 6.88% |
| Foresite Capital Management III, LLC | 204,088 | $24,021,000 | 6.25% |